4
Changes in Ownership
Fulcrum Therapeutics, Inc. Filed Acc 0000950170-24-009096
Options or other derivatives
- Vice President, Finance acquired 93,820 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Tourangeau Greg Vice President, Finance | 2024-01-26 | Grant or award · Stock Option (right to buy) | +83,820 | 83,820 | D | ||
| Tourangeau Greg Vice President, Finance | 2024-01-26 | Grant or award · Stock Option (right to buy) | +10,000 | 10,000 | D | ||
Loading xslF345X05/ownership.xml…